InvestSMART

Suda Pharmaceuticals Ltd (ASX: SUD) - Announcements

- Current share price for SUD : $0.048

ASX company news and announcements for Suda Pharmaceuticals Ltd (SUD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Suda Pharmaceuticals Ltd (SUD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Suda Pharmaceuticals Ltd (SUD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Suda Pharmaceuticals Ltd (SUD)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- SUDA Launches New Website 31 May 2019 12:09PM $0.007 $0.048 risen by 585.71%
- Media Article 27 May 2019 8:32AM $0.005 $0.048 risen by 860%
- Overview of David Phillips 20 May 2019 1:56PM $0.006 $0.048 risen by 772.73%
- Final Director's Interest Notice 17 May 2019 5:03PM $0.005 $0.048 risen by 860%
- Initial Director's Interest Notice 17 May 2019 12:19PM $0.006 $0.048 risen by 700%
- SUDA Restructures Board 17 May 2019 8:23AM $0.005 $0.048 risen by 860%
- Paul Hopper Appointed Chairman 15 May 2019 8:29AM $0.003 $0.048 risen by 1,500%
- Product Development Market Update 13 May 2019 9:17AM $0.004 $0.048 risen by 1,100%
- Appendix 4C - quarterly 30 Apr 2019 1:35PM $0.004 $0.048 risen by 1,100%
- ArTiMist Regulatory Update 18 Apr 2019 3:43PM $0.005 $0.048 risen by 966.67%
- Trading Halt 18 Apr 2019 9:09AM $0.004 $0.048 risen by 1,100%
- SUDA Submits MAA For ZolpiMist 4 Apr 2019 8:22AM $0.004 $0.048 risen by 1,100%
- Initial Director's Interest Notice 28 Mar 2019 12:49PM $0.005 $0.048 risen by 966.67%
- SUDA Appoints David Simmonds To The Board 27 Mar 2019 8:29AM $0.004 $0.048 risen by 1,100%
- Program Update Anagrelide 15 Mar 2019 8:23AM $0.005 $0.048 risen by 860%
- Top 20 securityholders 1 Mar 2019 5:18PM $0.004 $0.048 risen by 1,100%
- Half Yearly Report and Accounts 28 Feb 2019 7:16PM $0.004 $0.048 risen by 1,100%
- Program Update Anagrelide 21 Feb 2019 8:24AM $0.005 $0.048 risen by 860%
- SUDA Continues To Expand Patent Coverage 18 Feb 2019 1:06PM $0.006 $0.048 risen by 772.73%
- Appendix 3B 4 Feb 2019 6:22PM $0.005 $0.048 risen by 860%
- Appendix 4C Amended 4 Feb 2019 5:04PM $0.005 $0.048 risen by 860%
- Appendix 4C - quarterly 31 Jan 2019 8:25AM $0.005 $0.048 risen by 860%
- SUDA Signs Agreement With Mitsubishi Tanabe 19 Dec 2018 8:23AM $0.005 $0.048 risen by 860%
- ZLD: ZLD to Invest in Development of Oral Spray Formulations 6 Dec 2018 8:53AM $0.006 $0.048 risen by 700%
- SUDA Enters Agreement To Develop Cannabinoid Spray 6 Dec 2018 8:24AM $0.006 $0.048 risen by 700%

176 - 200 of 445 results

Page 8 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.